The Role of Antifibrinolytics and Haemostatic Agents in Pillar II: Are We Making the Most of the Evidence?
Update in Anaesthesia · 10.04.2026 · 42
DOI: 10.28923/uia.42.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Update in Anaesthesia, online erschienen am 10.04.2026. Verfasst von Orawan Pongraweewen und 3 weiteren Autor:innen. Die Arbeit nennt 114 Literaturangaben.
Abstract (Originalsprache)
Patient blood management is a multimodal, multidisciplinary approach designed to optimise the management of the patient’s blood. Within this framework, Pillar II specifically focuses on minimising blood loss and optimising coagulation. Although surgical techniques are fundamental to this pillar, the pharmacological management of haemostasis using antifibrinolytics and haemostatic agents has emerged as a critical component of modern care. This article critically evaluates the current evidence supporting the use of tranexamic acid, fibrinogen concentrates, and prothrombin complex concentrates in major surgery and trauma. The robust evidence from landmark trials such as CRASH-2 and WOMAN showing reduced death due to bleeding with early tranexamic acid, and FIBRES demonstrating non-inferior clinical efficacy of fibrinogen concentrate versus cryoprecipitate, clinical adoption remains inconsistent. We explore the “implementation gap” and the disparity between high-level evidence and bedside practice, particularly regarding the timing of administration and the reliance on empiric fixed-ratio massive transfusion protocols over goal-directed bleeding management. The article argues that although we have powerful pharmacological tools to stabilise the “lethal triad” of coagulopathy, acidosis, and hypothermia, we are not yet maximising their potential. By integrating point-of care viscoelastic haemostatic assays and adhering to evidence-based dosing and timing, clinicians can significantly improve patient outcomes and resource utilisation within PBM Pillar II.
Zitieren
APA
Pongraweewen, O., Trifa, M., Goldberg, I. S., & Behaine, J. J. M. (2026). The Role of Antifibrinolytics and Haemostatic Agents in Pillar II: Are We Making the Most of the Evidence?. Update in Anaesthesia, 42. https://doi.org/10.28923/uia.42.4
Vancouver
Pongraweewen O, Trifa M, Goldberg IS, Behaine JJM. The Role of Antifibrinolytics and Haemostatic Agents in Pillar II: Are We Making the Most of the Evidence?. Update in Anaesthesia. 2026;42. doi:10.28923/uia.42.4
BibTeX
@article{Pongraweewen2026,
author = {Pongraweewen, Orawan and Trifa, Mehdi and Goldberg, Ignacio Sarmiento and Behaine, Juan Jose Morales},
title = {The Role of Antifibrinolytics and Haemostatic Agents in Pillar II: Are We Making the Most of the Evidence?},
journal = {Update in Anaesthesia},
year = {2026},
volume = {42},
doi = {10.28923/uia.42.4}
}
EUVIMED